News | April 06, 2015

SCAI 2015 Opening Session to Highlight Disruptive Technologies in Cardiovascular Care

Drs. Peter Fitzgerald and Christian Assad-Kottner will examine impacts of rising costs, variability in care and encourage physicians to embrace change

April 6, 2015 — The opening session speakers at the Society for Cardiovascular Angiography and Interventions (SCAI) 2015 Scientific Sessions will examine the current state of cardiovascular care and why it is ripe for disruption and new technologies. Peter Fitzgerald, M.D., Ph.D., of Stanford University, and Christian Assad-Kottner, M.D., of the Fogarty Institute for Innovation and El Camino Hospital in Mountain View, California, will explore how increasing costs and variability in healthcare provide the potential to change how cardiovascular care is provided. SCAI 2015 will be held in San Diego May 6-9.

“Variability in care, health system consolidation and increasing financial pressures are driving an increasing need for standardization,” said Fitzgerald. “At the same time, innovative companies like Apple, Google and Samsung are entering healthcare. This convergence will drive greater change in how interventional cardiologists provide care, and it’s something we can all embrace.”

In his presentation, Fitzgerald will share examples of how emerging technologies will lead to better care. “Incredible point-of-care diagnostics are available today,” he said. “Soon we’ll be able to model the size and length of stent needed before we get to the cath lab. And we’ll be able to better assess the patient’s outcomes – that’s exciting because we can provide even better care, more efficiently and possibly for more patients.”

Interventional cardiologists will also need to understand and use new exponential technologies, which are types of technologies that rapidly evolve even as they fundamentally change medicine, according to Assad-Kottner. Examples include 3-D printing, robotics, genomics, sensors and artificial intelligence. Physicians are just beginning to understand and evaluate how these and other technologies can impact patient care.

“We have the ability to take our medical knowledge and use new technologies to creatively solve the problems we face today,” said Assad-Kottner.

Already, young physicians are beginning not only to embrace these changes but also to demand them, said Fitzgerald. As medical schools broaden their focus to include business, healthcare economics and information technology, young physicians are entering the field better prepared for the changes that are ahead.

“The students are demanding the change,” said Fitzgerald. “Our 30-year-olds are emerging from medical schools with so much more in their armamentarium. Still, there’s a lot of wisdom experienced interventional cardiologists can share to improve these new systems. We all need to get involved because it’s an exciting time for the field of interventional cardiology.”

For more information:

Related Content

DISRUPT BTK Study Shows Positive Results With Lithoplasty in Calcified Lesions Below the Knee
News | Peripheral Artery Disease (PAD)| September 20, 2017
Shockwave Medical reported positive results from the DISRUPT BTK Study, which were presented at the annual...
Corindus Announces First Patient Enrolled in PRECISION GRX Registry
News | Robotic Systems| September 18, 2017
September 18, 2017 — Corindus Vascular Robotics Inc.
Two-Year ILLUMENATE Trial Data Demonstrate Efficacy of Stellarex Drug-Coated Balloon
News | Drug-Eluting Balloons| September 18, 2017
Philips announced the two-year results from the ILLUMENATE European randomized clinical trial (EU RCT) demonstrating...
Sentinel Cerebral Protection System Significantly Reduces Stroke and Mortality in TAVR
News | Embolic Protection Devices| September 18, 2017
September 18, 2017 – Claret Medical announced publication of a new study in the...
Fysicon Receives FDA Approval for QMAPP Hemodynamic Monitoring System
Technology | Hemodynamic Monitoring Systems| September 18, 2017
Fysicon announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its...
Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Feature | Cath Lab| September 14, 2017
September 14, 2017 — Here are quick summaries for all the key late-breaking vascular and endovascular clinical trials
Mississippi Surgical and Vascular Center Uses Toshiba Ultimax-i FPD to Save Patients' Limbs
News | Angiography| September 14, 2017
The southern U.S. sees some of the highest numbers of chronic medical conditions, such as peripheral artery disease...
Sponsored Content | Videos | Structural Heart Occluders| September 13, 2017
Ziyad Hijazi, M.D., MPH, MSCAI, FACC, director of the cardiac program and chair of the Department of Pediatrics at Si
Philips Showcases Integrated Vascular Solutions at VIVA 2017
News | Peripheral Artery Disease (PAD)| September 13, 2017
Philips announced its presence at the Vascular Interventional Advances (VIVA 17) Annual Conference in Las Vegas from...
Medtronic Announces Japanese Regulatory Approval for In.Pact Admiral Drug-Coated Balloon
News | Drug-Eluting Balloons| September 13, 2017
Medtronic plc announced that the In.Pact Admiral Drug-Coated Balloon (DCB) received approval from the Japanese Ministry...
Overlay Init